Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 133, Issue 2
January 10 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

Hematopoiesis and Stem Cells
BID-ding on necroptosis in MDS
Ben A. Croker,Michelle A. Kelliher
View Articletitled, BID-ding on necroptosis in MDS
CLINICAL TRIALS AND OBSERVATIONS
Resolved HBV and anti-CD20 therapy
Clinical Trials & Observations
Lisa K. Hicks,Jordan J. Feld
View Articletitled, Resolved HBV and anti-CD20 therapy

PLENARY PAPER

Hematopoiesis and Stem Cells
Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice
Patrice N. Wagner,Qiong Shi,Christi T. Salisbury-Ruf,Jing Zou,Michael R. Savona,Yuri Fedoriw,Sandra S. Zinkel
View Articletitled, Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice
Supplemental data

PERSPECTIVE

Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?
Clinical Trials & Observations
Maryam Sarraf Yazdy,Anthony R. Mato,Bruce D. Cheson
View Articletitled, Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?

HOW I TREAT

How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia
Clinical Trials & Observations
Farhad Ravandi
View Articletitled, How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia

CLINICAL TRIALS AND OBSERVATIONS

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Clinical Trials & Observations
Shigeru Kusumoto,Luca Arcaini,Xiaonan Hong,Jie Jin,Won Seog Kim,Yok Lam Kwong,Marion G. Peters,Yasuhito Tanaka,Andrew D. Zelenetz,Hiroshi Kuriki,Günter Fingerle-Rowson,Tina Nielsen,Eisuke Ueda,Hanna Piper-Lepoutre,Gila Sellam,Kensei Tobinai
View Articletitled, Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy
Supplemental data
Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR
Clinical Trials & Observations
Meletios Dimopoulos,David Siegel,Darrell J. White,Ralph Boccia,Karim S. Iskander,Zhao Yang,Amy S. Kimball,Khalid Mezzi,Heinz Ludwig,Ruben Niesvizky
View Articletitled, Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR
Supplemental data

LYMPHOID NEOPLASIA

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
Elisa Bergaggio,Chiara Riganti,Giulia Garaffo,Nicoletta Vitale,Elisabetta Mereu,Cecilia Bandini,Elisa Pellegrino,Verdiana Pullano,Paola Omedè,Katia Todoerti,Luciano Cascione,Valentina Audrito,Anna Riccio,Antonio Rossi,Francesco Bertoni,Silvia Deaglio,Antonino Neri,Antonio Palumbo,Roberto Piva
View Articletitled, IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
Supplemental data

MYELOID NEOPLASIA

Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy
The Duy Nguyen,Shabnam Shaid,Olesya Vakhrusheva,Sebastian E. Koschade,Kevin Klann,Marlyn Thölken,Fatima Baker,Jing Zhang,Thomas Oellerich,Duran Sürün,Anja Derlet,Isabella Haberbosch,Stefan Eimer,Heinz D. Osiewacz,Christian Behrends,Christian Münch,Ivan Dikic,Christian H. Brandts
View Articletitled, Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy
Supplemental data

BLOOD WORK

One translocation for 2 lymphoid neoplasms
Guillaume Aussedat,Lucile Baseggio
View Articletitled, One translocation for 2 lymphoid neoplasms
Relapsed NPM1 mutated acute myeloid leukemia with PDGFRA rearrangement
Gokce A. Toruner,Beenu Thakral
View Articletitled, Relapsed <em>NPM1</em> mutated acute myeloid leukemia with <em>PDGFRA</em> rearrangement
Neutrophilic leukemoid reaction associated with plasma cell neoplasm mimicking chronic neutrophilic leukemia
Wei Xie,Jie Xu
View Articletitled, Neutrophilic leukemoid reaction associated with plasma cell neoplasm mimicking chronic neutrophilic leukemia
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals